Press Release: Romark Laboratories, L.C : Stonehenge Capital invests New Markets Tax Credits in Romark Global Pharma to build new manufacturing facility in Puerto Rico

Stonehenge Capital, in partnership with Capital One, Mid-City Community, Empowerment Reinvestment Fund and HEDC New Markets, today announced a $33 million investment in New Markets Tax Credit financing for Romark Global Pharma LLC. The $33 million NMTC investment provides final financing required for completion of Romark’s pharmaceutical manufacturing project in Manatí.